The Asia Pacific small animal imaging market is estimated to grow from $XX million in 2018 to $XX million by 2027, at a CAGR of 9.63% between 2019 and 2027. Government plant to streamline clinical trial in China for drug discovery and development is boosting growth in China small animal imaging market.
Asia-pacific is a highly lucrative market for small animal imaging device manufacturers, owing to the availability of a large skilled labor base and improving healthcare infrastructure in terms of advanced imaging devices. Asia Pacific small animal imaging market is expected to be on up-surging trend owing to proactive government initiatives to support the R&D to develop novel drugs and medication using new small animal imaging tests. The countries of India, China, Japan, South Korea, Australia and the Rest of Asia Pacific regional segment are considered for market analysis.
MILabs B.V., Miltenyi Biotec, ESaote S.P.A, GE Healthcare, Fujifilm Holdings Corporation, Perkinelmer, Inc., MR Solutions Ltd., Agilent Technologies, Inc., Shimadzu Corporation, Bruker Corporation, Aspect Imaging, Hitachi Medical Corporation, Olympus Corporation, Siemens Healthcare GmbH, and MindRay are the major companies operating in the market.